HCPCS Level II › M codes › M0233

M0233

Intravenous infusion, tocilizumab-aazg, for hospitalized adult patients with covid-19 who are receiving systemic corticosteroids and require supplemental oxygen, non-invasive or invasive mechanical ventilation, or extracorporeal membrane oxygenation (ecmo) only, includes infusion and post administration monitoring, first dose

ValidHCPCS Level II code.

Valid for claims with a date of service in the current code year.

Valid FY2026 onwards.

What has happened to this code

Every change the publisher made, from 2026 to now.

  1. April 2026 Added to the code set Intravenous infusion, tocilizumab-aazg, for hospitalized adult patients with covid-19 who are receiving systemic corticosteroids and require supplemental oxygen, non-invasive or invasive mechanical ventilation, or extracorporeal membrane oxygenation (ecmo) only, includes infusion and post administration monitoring, first dose